P TOTAL NUMBER OF PAYMENTS

Charles Engh
Arlington

Randall Lewis
Chevy Chase, Md.

Laurence OHalloran
Falls Church

Raymond Thal
Reston

TOTAL AMOUNT PAID P

$4,628,773
1,313,205
872,116

MOU

Zobair Younossi
Washington

119

645,782

Ronald Jackson
Middleburg

40

642,327

TOP 25 PAID DOCTORS IN GREATER WASHINGTON

NT P
AID

P AV E R
AG E
PAY
M

$36,297,171
EN

L AMO
TOTA

TS

U N T PA I D P

27.4%

$11,885,599

ENT SIZE P
M
Y
A
GE P
A
R
$2,920
E
AV
N TS P
PAY M E
F
O
BER
5,732
M
NU

EDITORS NOTE: The graphs at left and right may not

reflect recent changes to the Open Payments database.

IZE
P NUM
BER
OF
PAY
ME
33,2
NT
98
S

$9

569,561

96
3

6,

513,248

91
14

4,

63

$5

Randall Peyton
Sterling

76

782

We combed through the Centers for Medicare & Medicaid Services

Open Payments database to find the 25 doctors in D.C., Northern
Virginia and suburban Maryland who received the most nonresearchrelated payments from drug and medical device companies in 2015.
Go online to www.washingtonbusinessjournal.com for a complete
searchable database of all doctors in the region.

83.8%

645,874

812

Farhad Zangeneh
Sterling

P TOTA L
A

762,646

Ralph Boccia
Germantown

WHO GOT WHAT

Heidi Crayton
Vienna

755

375,948
368,464

Laxman Bahroo
Washington

331,306

539

Helena Rodbard
Rockville

301

Niku Singh
McLean

515

Scott Kahan
Washington

299

320,247
296,625

Steven Nathan
Falls Church

259,644
206,973

169

196,612

364

Benjamin Lockshin
Silver Spring

193,861

279

Joseph OBrien
Washington

134

191,299

Faheem Sandhu
Clinton

94

191,184

John Hogan
Washington

274

Fahd Amjad
Washington

290

Charles Engh

$661,253

Helen Barold

368,464

Randall Lewis

218,867

Laurence OHalloran

96,902

Raymond Thal

95,331

Ronald Jackson

16,058

40

Timothy Cote

11,947

17

Randall Peyton

8,147

63

Zobair Younossi

5,427

119

Imadeddine Tabbara

2,177

415

Faheem Sandhu

2,034

94

Joseph OBrien

1,428

134

Steven Nathan

1,225

169

Helena Rodbard

1,064

301

Maurice Nahabedian

971

387

Scott Kahan

868

299

Ralph Boccia

795

812

Farhad Zangeneh

728

782

Benjamin Lockshin

695

279

John Hogan

686

274

Laxman Bahroo

615

539

Fahd Amjad

585

290

Niku Singh

576

515

Ramon Mendez

540

364

Heidi Crayton

529

755

188,071

HOW DOCTORS
RECEIVED PAYMENT

Speaker fees and royalty

or license payments
represented more than half
of the payments, or more
than $22 million.

The bulk of payments to local

doctors in 2015 about
$36 million of the $43 million
given, were made as cash or
cash equivalents, according
to the database.

Speaker fees
Royalty or license
Consulting fee
Food and beverage
Travel and lodging
Grant
Education
Honoraria
Facility fees
Gift
Investment interest
Charitable contribution
Entertainment

$40

Cash or cash
equivalent
In-kind items
and services
Dividend, profit
or other return
on investment

15.4%

$6,647,918

$8

,7

9.1%

$3,937,022

03
11,04

8.8%

$42,693,041

16.2%

SOURCE: Centers for Medicare & Medicaid

Services Open Payments database

4.4%: $1,903,685
2.7%: $1,161,452
1.3%: $571,827

0.0%: $1,067

4.8%

$2,075,167

0.7%: $294,618
0.5%: $237,909
0.3%: $124,496

0.01%: $4,356

RThe Open Payments database also lists how much drug and device companies pay out every year. This chart shows that DePuy Synthes Products
was far and above the biggest payor to local doctors (a big chunk of that was a royalty payment to Dr. Charles Engh). DePuy paid more than twice as much
as the next company, Zimmer Biomet Holdings Inc. Go to www.washingtonbusinessjournal.com for a complete list of companies local spending.

TOP 25 COMPANIES MAKING PAYMENTS TO LOCAL DOCTORS

P TOTAL NUMBER OF PAYMENTS
565

Zimmer Biomet
Holdings Inc.

752

Gilead Sciences
Inc.
Medtronic
Vascular Inc.
AbbVie Inc.
Amgen Inc.
Medtronic
Xomed Inc.
Boston Scientific
Corp.
AstraZeneca
Pharmaceuticals LP
Janssen
Pharmaceuticals Inc.
Merck Sharp &
Dohme Corp.

TOTAL AMOUNT PAID P

$5,607,979
2,086,091
1,594,494

1,081

1,087,158

2,689

1,080,512

10,302

771,218

608

724,182

7,740

Stryker Corp.

5,162

703,669

E.R. Squibb &

Sons LLC
Allergan Inc.
Novartis
Pharmaceuticals Corp.
Celgene Corp.
Takeda Pharmaceuticals
America Inc.
LifeCell Corp.

Payor

833,764

1,189

669,152

6,705

631,752

158
2,769

616,429

RERANKED BY AVERAGE PAYMENT SIZE

Name

Type 2 diabetes

Boston Scientific Corp.

1,722

174

Novartis Pharmaceuticals Corp.

Gilenya

Multiple sclerosis

159,488

AbbVie Inc.

1,509

1,263

Teva Pharmaceuticals USA Inc.

Azilect

Parkinsons disease

152,725

AstraZeneca Pharmaceuticals LP

1,402

1,189

Genentech USA Inc.

854

601

Teva Pharmaceuticals USA Inc.

Nuvigil

Sleepiness from narcolepsy, shift

work

144,167

Abbott Laboratories

815

1,563

Amgen Inc.

Repatha

143,070

Genzyme Corp.

640

605

Atherosclerosis in coronary heart

disease

DePuy Synthes Products LLC

458

565

AstraZeneca Pharmaceuticals LP

Brilinta

Blood thinner, prevention of heart

attack, stroke

141,947

Medtronic Vascular Inc.

432

6,192

GlaxoSmithKline LLC

Tanzeum

Type 2 diabetes

138,201

Alexion Pharmaceuticals Inc.

Soliris

Paroxysmal nocturnal
hemoglobinuria (PNH) and atypical
hemolytic uremic syndrome

138,063

Lilly USA LLC

Jardiance

Type 2 diabetes

135,467

E.R. Squibb & Sons LLC

Opdivo

Non-small cell lung cancer

133,687

US WorldMeds LLC

Myobloc

Cervical dystonia

132,778

AstraZeneca Pharmaceuticals LP

Bydureon

Type 2 diabetes

130,044

Amgen Inc.

Corlanor

Chronic heart failure

126,194

Amgen Inc.

Kyprolis

Multiple myeloma

125,389

Sanofi-Aventis U.S. LLC

Aubagio

Multiple sclerosis

119,154

Celgene Corp.

Revlimid

Multiple myeloma

115,606

Novartis Pharmaceuticals Corp.

Cosentyx

Plaque psoriasis

115,275

Pfizer Inc.

Eliquis

Anticoagulant

115,252

Boehringer Ingelheim
Pharmaceuticals Inc.

Pradaxa

Blood clot prevention

111,439

Celgene Corp.

324

1,786

Takeda Pharmaceuticals America Inc.

279

2,851

Zimmer Biomet Holdings Inc.

219

752

LifeCell Corp.

186

4,457

Teva Pharmaceuticals USA Inc.

178

2,769

Pfizer Inc.

173

6,705

Stryker Corp.

153

5,162

Merck Sharp & Dohme Corp.

127

7,740

98

10,302

480,098

SOURCE: Centers for Medicare & Medicaid Services Open Payments database

TOP CITIES BY PAYMENTS

This map and chart show doctors in which cities received the most money from drug and medical device
companies in 2015. The numbers represent the cities proper, not their metropolitan areas. Washington, D.C.,
proper received $15,937,725, ranking it as No. 25 on this list. Our region as a whole received $42.7 million.
19

15
11

5
18
25

17

1
14
6

10

Blood thinner, deep vein thrombosis,

pulmonary embolism

Victoza

994

16

Xarelto

Novo Nordisk Inc.

WHERE THE PAYMENTS GO

347,482

608

328

12

Type 2 diabetes

1,756

Boehringer Ingelheim Pharmaceuticals Inc.

Invokana

Janssen Pharmaceuticals Inc.

Medtronic Xomed Inc.

Genzyme Corp.

Janssen Pharmaceuticals Inc.

Neurogenic orthostatic hypotension

2,689

605

354,146

Northera

347

481,250

Weight loss

Lundbeck LLC

Amgen Inc.

Genentech USA Inc.

Contrave

796

587,768

601

Takeda Pharmaceuticals America Inc.

406,478

2,509

1,081

491,218

Cord Blood cell therapy

Allergan Inc.

383

994

HemaCord

158

Gilead Sciences Inc.

Boehringer Ingelheim
Pharmaceuticals Inc.

New York Blood Center Inc.

$959,495

5,644

1,297

532,632

Rheumatoid arthritis, Crohns

disease

Kerr Corp.

419

4,457

Humira

Janssen Pharmaceuticals Inc.

E.R. Squibb & Sons LLC

574,702

AbbVie Inc.

4,337

591,334

2,851

Total spent

$101,878

Novartis Pharmaceuticals Corp.

796

582,264

Drug use

Number of
payments

600,869

1,786

Drug

Average
payment size

1,297

4,337

Humira, which is sold by Abbott Laboratories spinout AbbVie Inc., represented

the most spending among drugs in the Washington region last year. Nearly
$960,000 was spent promoting the immunosuppressant with varying uses, from
rheumatoid arthritis to Crohns disease.
When it comes to devices, orthopedics is the clear priority. Combining different
focus areas from the regions top 25 marketed devices including hips, spine and
knee devices, at least a third of spending went toward the specialty.

TOP 25 DRUGS BY SPENDING

865,441

174

716,400

Teva Pharmaceuticals
USA Inc.

Five of the top 25 drugs promoted by drug companies in Greater Washington

treat Type 2 diabetes. Four more of those top drugs are blood thinners, while two
more treat multiple sclerosis.
Dr. Adriane Fugh-Berman, an expert on drug payments who works at
Georgetown University and the affiliated Medstar Georgetown University
Hospital, said these drugs have a common theme: They are more expensive than
cheaper generic versions offering the same or better mortality rates.

1,184,015

1,263

1,563

Kerr Corp.

THE DRUG PRIORITIES

1,244,459

6,192

Abbott Laboratories

Pfizer Inc.

$6,595

$3,832,112

Total payments to Greater Washington doctors

$7,006,671

WHERE THE PAYMENTS CAME FROM

DePuy Synthes
Products LLC

4,363

Check out our complete searchable

database of all doctors in the region
at washingtonbusinessjournal.com

169,616

$10,628,748

96

Ramon Mendez
Bethesda

Number of
payments

,5

203,104

17

Average
payment size

AND WHY
THEY DID

24.5%

$2

Timothy Cote
Silver Spring

Name

399,584

387

Helen Barold
Washington

RERANKED BY AVERAGE PAYMENT SIZE

,547

Maurice Nahabedian
Washington

434,221

$1
,0
67

415

138

Imadeddine Tabbara
Washington

20
13

City

Amount
$307,442,256

182,145

This chart shows which areas medical device companies made their payments
to local doctors in 2015. Orthopedics was the leading specialty for devices,
representing twice as much as the next area, hips.

Duarte, CA

New York, NY

Boston, MA

98,917,931

Los Angeles, CA

59,782,976

Philadelphia,PA

45,884,741

Dallas, TX

42,116,336

Hips

Houston, TX

41,943,466

Sinus surgery

Chicago, IL

35,299,273

North Kansas City, MO

34,650,242

Sports medicine

10

San Antonio, TX

34,414,870

11

Cleveland, OH

32,001,535

General dentistry

12

San Francisco, CA

29,374,732

AlloDerm

13

Atlanta, GA

27,842,741

14

Phoenix, AZ

26,483,154

Spine

15

Rochester, NY

24,597,454

16

Memphis, TN

17

TOP MEDICAL DEVICES BY SPENDING

Orthopedics

$4,710,118
1,745,252
872,170
758,630

Other

717,990
572,339
528,973
469,428

Vascular

419,431

24,152,342

Noncovered

415,000

San Diego, CA

21,167,330

Thoraoc-lumbar

404,589

18

Baltimore, MD

20,520,118

19

Seattle, WA

19,564,064

Structural heart

20

Charlotte, NC

19,103,619

25

Washington, DC

15,937,725

SOURCE: Centers for Medicare & Medicaid Services Open Payments database

250,321

THE DEVICE PRIORITIES

107,286,296

300,081

SPY surgery syst.

226,536
204,591

Stents

201,621

Video imaging

194,501